Greater Binghamton Obstetrics & Gynecology, Pllc

CLIA Laboratory Citation Details

3
Total Citations
13
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 33D0714183
Address 365 Harry L Drive, Suite 110, Johnson City, NY, 13790
City Johnson City
State NY
Zip Code13790
Phone607 629-5805
Lab DirectorDOMENICO LEUCI

Citation History (3 surveys)

Survey - March 27, 2025

Survey Type: Standard

Survey Event ID: B87811

Deficiency Tags: D5291 D5403 D5291 D5403

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on review of laboratory systems Quality Assurance (QA) procedures, QA records, as well as interview with the Testing Person (TP), the laboratory failed to perform and document QA. FINDINGS: 1. There was no documentation of QA records for 2024. 2. This was contrary to instructions indicated in the current, approved QA Plan. 3. The TP confirmed the findings on March 27, 2025, at approximately 1:00 P.M. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) (b) The procedure manual must include the following when applicable to the test procedure: (b)(1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (b)(2) Microscopic examination, including the detection of inadequately prepared slides. (b)(3) Step-by- step performance of the procedure, including test calculations and interpretation of results. (b)(4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (b)(5) Calibration and calibration verification procedures. (b)(6) The reportable range for test results for the test system as established or verified in 493.1253. (b)(7) Control procedures. (b)(8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 29, 2021

Survey Type: Standard

Survey Event ID: H7L311

Deficiency Tags: D5291 D6021 D6021 D5417 D5417

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on a surveyor's review of Quality Assessment (QA) policy and confirmed in an interview with the laboratory testing person, the laboratory failed to follow their written QA policy for an ongoing mechanism to monitor, assess, and when indicated correct problems that may occur in the laboratory testing. FINDINGS: The laboratory testing person confirmed on January 29, 2021 at approximately 10:00 AM, the surveyor's findings that the laboratory did not follow the QA policy and perform an annual QA review for the calendar years 2019 and 2020, as required by their QA policy. Refer to D5417 D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on surveyor's observation, review of the patient urinalysis & urine pregnancy log sheets and an interview with the testing person, the laboratory failed to ensure that the McKesson Consult Diagnostic positive/negative urine controls and the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Quantimetrix Urine Dipper Controls were not used when they exceeded their expiration dates. FINDINGS: The testing person confirmed on January 29, 2021 at approximately 9:00 AM the surveyor's findings, the surveyor observed urine control materials, in the laboratory refrigerator, had exceeded their expiration dates. 1) McKesson Consult Diagnostic positive/negative pregnancy control Lot # CC00456 with expiration date of 11-30-20 2) Quantimetrix Urine Controls Level #1 Lot # 44791 and Level 2 Lot # 44792 with expiration dates of 11-30-20 3) Surveyor could not determine if the current Clarity urine pregnancy tests kit and the Roche Chemistrip 10SG & 2GP urine reagent test strips in use, were tested with the above expired control material. a. The laboratory did not record the urine control material lot numbers on the patient log sheet; therefore, surveyor could not determine the number of patient specimens tested with the pregnancy kit and urine test strips. D6021 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(5) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(5) Ensure that quality assessment programs are established and maintained to assure the quality of laboratory services provided. This STANDARD is not met as evidenced by: Based on a surveyor's review of the laboratory's QA policy and confirmed in an interview with the laboratory testing person, at this survey, the laboratory director failed to ensure that the laboratory's QA program was maintained for all phases of laboratory testing. Refer to: D5291 and D5417. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 24, 2018

Survey Type: Standard

Survey Event ID: VSS311

Deficiency Tags: D2007 D6016 D2007 D6016

Summary:

Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on the surveyor's review of Medical Laboratory Evaluation (MLE) proficiency testing (PT) attestation statements for 2016 and 2017, and an interview with the practice manager, the laboratory failed to rotate PT samples among the two testing persons who have routinely performed bacteriology, mycology, and parasitology testing with the BD Affirm VPIII analyzer. Findings: The practice manager confirmed on July 24, 2018 at approximately 11:15 AM that the Affirm testing has been performed by the same testing person for the third event of 2016 and for all three events of 2017. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on the surveyor's review of PT records and confirmed in an interview with the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- practice manager, the laboratory director failed to ensure that bacteriology, mycology and parasitology samples tested with the Affirm VPIII analyzer were tested in the same manner as patient samples. Refer to D2007. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access